# Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir

> **NCT01023217** · PHASE4 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 90 (actual)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** Adefovir
- **DRUG:** Entecavir
- **DRUG:** Lamivudine

## Key facts

- **NCT ID:** NCT01023217
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2012-07
- **Final completion:** 2012-09
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2014-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01023217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01023217, "Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01023217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*